Saturday - October 24, 2020
Piedmont Healthcare Enrolling Patients in Two COVID-19-Related Clinical Trials
May 06, 2020
ATLANTA, Georgia, May 6 -- Piedmont Healthcare issued the following news release:

Piedmont Healthcare will participate in two new clinical trials that will investigate therapies for patients who are positive for COVID-19: one that will evaluate the efficacy of the anti-inflammatory drug Gimsilumab and another that will investigate proning, or repositioning patients to improve their oxygen levels. These studies began enrolling patients in early May.

The studies are offic . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products